Showing results (1701-1710 of 10,079) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|July 18, 2017
Update of Standard Practices for New Method Validation in Forensic ToxicologySarah M R Wille, Wim Coucke, Thierry De Baere, et al.Current Pharmaceutical Design|July 18, 2017
Biomaterials and Supercritical Fluid Technologies: Which Perspectives to Fabricate Artificial Extracellular Matrix?G Della Porta, E Reverchon, N MaffulliCurrent Pharmaceutical Design|July 18, 2017
Aquaporin 4 in Astrocytes is a Target for Therapy in Alzheimer's DiseaseYu-Long Lan, Jian-Jiao Chen, Gang Hu, et al.Current Pharmaceutical Design|March 15, 2016
Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson's DiseaseJuan Camilo Jurado-Coronel, Marco Avila-Rodriguez, Francisco Capani, et al.Current Pharmaceutical Design|March 15, 2016
Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?Valentina Echeverria, J Alex Grizzell, George E BarretoCurrent Pharmaceutical Design|March 15, 2016
Stroke and Neuroinflamation: Role of Sexual HormonesMaria Jose Perez-Alvarez, Francisco WandosellCurrent Pharmaceutical Design|November 26, 2020
Therapeutic Management of COVID-19 Patients: Clinical Manifestation and LimitationsUrooj Fatima, Syed Saif A Rizvi, Neha Raina, et al.Current Pharmaceutical Design|September 4, 2020
The Ligands of Translocator Protein: Design and Biological PropertiesGrigory V Mokrov, Olga A Deeva, Tatiana A GudashevaCurrent Pharmaceutical Design|November 6, 2020
Covalent Docking in Drug Discovery: Scope and LimitationsAndrea Scarpino, György G Ferenczy, György M KeserűCurrent Pharmaceutical Design|November 6, 2020
Cardiovascular Risk in Patients with Primary HyperparathyroidismSymeon Tournis, Konstantinos Makris, Etienne Cavalier, et al.Pageof 1,008